StreetInsider.com News Articles

Nkarta to Participate in March Investor Conferences

Fri, 27 Feb 2026 08:00:00 -0500

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the following investor conferences:

March 2, 2026
TD Cowen 46th Annual Health Care Conference
Boston, MA
9:10 a.m. EST – fireside chat

March 10, 2026
Leerink Global Healthcare Conference
Miami, FL
10:40 a.m. EDT – fireside chat

A simultaneous webcast of both events will be available on the Investors section of Nkarta’s website, and a replay will

Nkarta to Participate in March Investor Conferences

Fri, 27 Feb 2026 08:00:00 -0500

Form SCHEDULE 13G/A Nkarta, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC

Tue, 17 Feb 2026 16:16:00 -0500

si-local-file:///var/storage/secattach/20260217/26013087.html

Form SCHEDULE 13G/A Nkarta, Inc. Filed by: TANG CAPITAL MANAGEMENT LLC

Tue, 17 Feb 2026 16:16:00 -0500

si-local-file:///var/storage/secattach/20260217/26013087.html

Form 4 Nkarta, Inc. For: Jan 15 Filed by: HASTINGS PAUL J

Tue, 20 Jan 2026 17:39:00 -0500

si-local-file:///var/storage/secattach/20260120/25869534.html

Form 4 Nkarta, Inc. For: Jan 15 Filed by: HASTINGS PAUL J

Tue, 20 Jan 2026 17:39:00 -0500

si-local-file:///var/storage/secattach/20260120/25869534.html

Form 4 Nkarta, Inc. For: Jan 15 Filed by: Mahmood Nadir

Tue, 20 Jan 2026 17:38:00 -0500

si-local-file:///var/storage/secattach/20260120/25869529.html

Form 4 Nkarta, Inc. For: Jan 15 Filed by: Mahmood Nadir

Tue, 20 Jan 2026 17:38:00 -0500

si-local-file:///var/storage/secattach/20260120/25869529.html

Form 4 Nkarta, Inc. For: Jan 06 Filed by: Rose Shawn Marshall

Thu, 08 Jan 2026 17:50:00 -0500

si-local-file:///var/storage/secattach/20260108/25827698.html

Form 4 Nkarta, Inc. For: Jan 06 Filed by: Rose Shawn Marshall

Thu, 08 Jan 2026 17:50:00 -0500

si-local-file:///var/storage/secattach/20260108/25827698.html

Form 4 Nkarta, Inc. For: Jan 06 Filed by: HASTINGS PAUL J

Thu, 08 Jan 2026 17:49:00 -0500

si-local-file:///var/storage/secattach/20260108/25827696.html

Form 4 Nkarta, Inc. For: Jan 06 Filed by: HASTINGS PAUL J

Thu, 08 Jan 2026 17:49:00 -0500

si-local-file:///var/storage/secattach/20260108/25827696.html

Form 4 Nkarta, Inc. For: Jan 06 Filed by: Mahmood Nadir

Thu, 08 Jan 2026 17:49:00 -0500

si-local-file:///var/storage/secattach/20260108/25827697.html

Form 4 Nkarta, Inc. For: Jan 06 Filed by: Mahmood Nadir

Thu, 08 Jan 2026 17:49:00 -0500

si-local-file:///var/storage/secattach/20260108/25827697.html

Form S-8 Nkarta, Inc.

Mon, 05 Jan 2026 16:44:00 -0500

si-local-file:///var/storage/secattach/20260105/25806041.html

Form S-8 Nkarta, Inc.

Mon, 05 Jan 2026 16:44:00 -0500

si-local-file:///var/storage/secattach/20260105/25806041.html

Nkarta to Participate in Evercore Healthcare Conference

Tue, 02 Dec 2025 07:09:00 -0500

SOUTH SAN FRANCISCO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the Evercore 8th Annual Healthcare Conference on Thursday in Miami.

Evercore 8th Annual Healthcare Conference
December 4, 2025
10:50 a.m. ET – fireside chat

A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, and a replay will be archived on the website for approximately 90 days.

About Nkarta
Nkarta is a clinical-stage biotechnology

Nkarta to Participate in Evercore Healthcare Conference

Tue, 02 Dec 2025 07:09:00 -0500

Evercore 8th Annual Healthcare Conference
December 4, 2025
10:50 a.m. ET – fireside chat

A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, and a replay will be archived on the website for approximately 90 days.

About Nkarta
Nkarta is a clinical-stage biotechnology

Nkarta to Participate in Evercore Healthcare Conference

Tue, 02 Dec 2025 07:09:00 -0500

Evercore 8th Annual Healthcare Conference
December 4, 2025
10:50 a.m. ET – fireside chat

A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, and a replay will be archived on the website for approximately 90 days.

About Nkarta
Nkarta is a clinical-stage biotechnology

Nkarta to Participate in Evercore Healthcare Conference

Tue, 02 Dec 2025 07:09:00 -0500

Evercore 8th Annual Healthcare Conference
December 4, 2025
10:50 a.m. ET – fireside chat

A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, and a replay will be archived on the website for approximately 90 days.

About Nkarta
Nkarta is a clinical-stage biotechnology

Form SCHEDULE 13D/A Nkarta, Inc. Filed by: Samsara BioCapital, L.P.

Mon, 24 Nov 2025 18:48:00 -0500

si-local-file:///var/storage/secattach/20251124/25657318.html

Form SCHEDULE 13D/A Nkarta, Inc. Filed by: Samsara BioCapital, L.P.

Mon, 24 Nov 2025 18:48:00 -0500

si-local-file:///var/storage/secattach/20251124/25657318.html

Form SCHEDULE 13G/A Nkarta, Inc. Filed by: CITADEL ADVISORS LLC

Fri, 14 Nov 2025 16:08:00 -0500

si-local-file:///var/storage/secattach/20251114/25616953.html

Form SCHEDULE 13G/A Nkarta, Inc. Filed by: CITADEL ADVISORS LLC

Fri, 14 Nov 2025 16:08:00 -0500

si-local-file:///var/storage/secattach/20251114/25616953.html

Nkarta Inc. (NKTX) PT Lowered to $16 at H.C. Wainwright

Tue, 11 Nov 2025 06:42:15 -0500

H.C. Wainwright analyst Emily Bodnar lowered the price target on Nkarta Inc. (NASDAQ: NKTX) to $16.00 (from $18.00) while maintaining a Buy rating.